Publication | Closed Access

Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats

InflammationMetabolic SyndromeAnti-inflammatoryAutoimmune DiseaseNitrosative StressDiabetes-induced NephropathyDiabetesImmunologyChronic Kidney DiseaseChronic InflammationPharmacologyStat3 InhibitorInflammatory BurdenDiabetic Kidney DiseaseMedicineNephrologyRheumatoid ArthritisOxidative Stress